Brookfield Corp’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-36,187
| Closed | -$7.89M | – | 665 |
|
|
2022
Q4 | $7.89M | Sell |
36,187
-13,895
| -28% | -$3.03M | 0.03% | 177 |
|
|
2022
Q3 | $9.86M | Buy |
50,082
+16,473
| +49% | +$3.24M | 0.04% | 160 |
|
|
2022
Q2 | $7.19M | Buy |
33,609
+5,406
| +19% | +$1.16M | 0.03% | 190 |
|
|
2022
Q1 | $8.01M | Buy |
28,203
+16,096
| +133% | +$4.57M | 0.03% | 180 |
|
|
2021
Q4 | $4.56M | Buy |
12,107
+4,308
| +55% | +$1.62M | 0.02% | 224 |
|
|
2021
Q3 | $3.22M | Buy |
7,799
+1,245
| +19% | +$514K | 0.01% | 274 |
|
|
2021
Q2 | $2.42M | Buy |
+6,554
| New | +$2.42M | 0.01% | 322 |
|
|
2020
Q4 | – | Sell |
-8,562
| Closed | -$1.94M | – | 453 |
|
|
2020
Q3 | $1.94M | Buy |
+8,562
| New | +$1.94M | 0.01% | 244 |
|